alexa A Novel Point-of-Care BioNanoSensor for Rapid HIV Detec
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

A Novel Point-of-Care BioNanoSensor for Rapid HIV Detection and Treatment Monitoring

Tomasz Rozmyslowicz1*, Johann deSa2, Ryszard Lec2and Glen N Gaulton1

1Department of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia, USA

2School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, USA

*Corresponding Author:
Tomasz Rozmyslowicz
Department of Pathology
University of Pennsylvania
R. 272 John Morgan Bldg
3620 Hamilton Walk
Philadelphia, PA 19104 USA
Tel: 1-215-898-2874
Fax: 1-215-573-7945
E-mail: [email protected]

Received date: March 25, 2015; Accepted date: April 28, 2015; Published date: May 08, 2015

Citation: Rozmyslowicz T, deSa J, Lec R, Gaulton GN (2015) A Novel Point-of-Care BioNanoSensor for Rapid HIV Detection and Treatment Monitoring. J AIDS Clin Res 6:454. doi:10.4172/2155-6113.1000454

Copyright: ©2015 Rozmyslowicz T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



We report here a new diagnostic approach to the direct detection of HIV in blood or other body fluids that is rapid, sensitive and potentially applicable in a point-of-care setting. The approach follows on the development of a novel BioNanoSensor (BNS) device that utilizes piezoelectric technology to detect the presence of the HIV surface glycoprotein gp120 in a nanoscale format. The detection range of the BNS device for the biomarker gp120 displayed a low-end sensitivity of 6.5×104 HIV viral particles/ml, while using a small fluid sample (5 μl) and with a reaction time of less then 30 seconds. Performance of this device indicated that the BNS has utility for direct detection of HIV particles prior to, and independent from, antibody formation. Accordingly, this device holds utility to monitor the status of HIV infection both early after exposure to virus as well as during chronic HIV infection. The BNS parameters of small sample volume, compact device size, and detection sensitivity indicate that the BNS is potentially useful in the pointof- care and/or home setting for monitoring decisions regarding HIV treatment on a real-time basis.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version